Global Alpha Glucosidase Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD036953
  • August 2019
  • GIR (GlobalInfoResearch)
                          

The Global Alpha Glucosidase Inhibitors Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day.

Scope of the Report:
Acarbose is the most widely prescribed of the three currently available (Acarbose, Miglitol, and Voglibose) alpha‚Äźglucosidase inhibitors and has been used in the management of hyperglycemia for years. 

The worldwide market for Alpha Glucosidase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Alpha Glucosidase Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •  Pfizer
  •  Bayer pharma
  •  Takeda
  •  Sun pharma
  •  Glenmark pharma
  •  Torrent
  •  Hexalag
  •  Unichem

Market Segment by Regions, regional analysis covers
  •  North America (United States, Canada and Mexico)
  •  Europe (Germany, France, UK, Russia and Italy)
  •  Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •  South America (Brazil, Argentina, Colombia etc.)
  •  Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •  Dumping Syndrome
  •  Type 2 Diabetes

Market Segment by Applications, can be divided into
  •  Online Pharmacies
  •  Retail Pharmacies
  •  Hospital Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha Glucosidase Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha Glucosidase Inhibitors, with price, sales, revenue and global market share of Alpha Glucosidase Inhibitors in 2017 and 2018.
Chapter 3, the Alpha Glucosidase Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha Glucosidase Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alpha Glucosidase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alpha Glucosidase Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Alpha Glucosidase Inhibitors Introduction
    1.2 Market Analysis by Type
        1.2.1 Dumping Syndrome
        1.2.2 Type 2 Diabetes
    1.3 Market Analysis by Applications
        1.3.1 Online Pharmacies
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Business Overview
        2.1.2 Alpha Glucosidase Inhibitors Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Pfizer Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Bayer pharma
        2.2.1 Business Overview
        2.2.2 Alpha Glucosidase Inhibitors Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Bayer pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Takeda
        2.3.1 Business Overview
        2.3.2 Alpha Glucosidase Inhibitors Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Takeda Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Sun pharma
        2.4.1 Business Overview
        2.4.2 Alpha Glucosidase Inhibitors Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Sun pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Glenmark pharma
        2.5.1 Business Overview
        2.5.2 Alpha Glucosidase Inhibitors Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Glenmark pharma Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Torrent
        2.6.1 Business Overview
        2.6.2 Alpha Glucosidase Inhibitors Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Torrent Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Hexalag
        2.7.1 Business Overview
        2.7.2 Alpha Glucosidase Inhibitors Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Hexalag Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Unichem
        2.8.1 Business Overview
        2.8.2 Alpha Glucosidase Inhibitors Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Unichem Alpha Glucosidase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alpha Glucosidase Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Alpha Glucosidase Inhibitors Manufacturer Market Share in 2018
        3.3.2 Top 6 Alpha Glucosidase Inhibitors Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Alpha Glucosidase Inhibitors Market Analysis by Regions
    4.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Regions
        4.1.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Regions (2014-2019)
    4.2 North America Alpha Glucosidase Inhibitors  Sales and Growth Rate (2014-2019)
    4.3 Europe Alpha Glucosidase Inhibitors  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Alpha Glucosidase Inhibitors  Sales and Growth Rate (2014-2019)
    4.5 South America Alpha Glucosidase Inhibitors  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Alpha Glucosidase Inhibitors  Sales and Growth Rate (2014-2019)
5 North America Alpha Glucosidase Inhibitors by Country
    5.1 North America Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Country
        5.1.1 North America Alpha Glucosidase Inhibitors Sales and Market Share by Country (2014-2019)
        5.1.2 North America Alpha Glucosidase Inhibitors Revenue and Market Share by Country (2014-2019)
    5.2 United States Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    5.3 Canada Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    5.4 Mexico Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
6 Europe Alpha Glucosidase Inhibitors by Country
    6.1 Europe Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Country
        6.1.1 Europe Alpha Glucosidase Inhibitors Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Alpha Glucosidase Inhibitors Revenue and Market Share by Country (2014-2019)
    6.2 Germany Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    6.3 UK Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    6.4 France Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    6.5 Russia Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    6.6 Italy Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
7 Asia-Pacific Alpha Glucosidase Inhibitors by Country
    7.1 Asia-Pacific Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Alpha Glucosidase Inhibitors Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Alpha Glucosidase Inhibitors Revenue and Market Share by Country (2014-2019)
    7.2 China Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    7.3 Japan Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    7.4 Korea Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    7.5 India Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
8 South America Alpha Glucosidase Inhibitors by Country
    8.1 South America Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Country
        8.1.1 South America Alpha Glucosidase Inhibitors Sales and Market Share by Country (2014-2019)
        8.1.2 South America Alpha Glucosidase Inhibitors Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    8.3 Argentina Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    8.4 Colombia Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
9 Middle East and Africa Alpha Glucosidase Inhibitors by Countries
    9.1 Middle East and Africa Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Alpha Glucosidase Inhibitors Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Alpha Glucosidase Inhibitors Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    9.3 Turkey Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    9.4 Egypt Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    9.5 Nigeria Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
    9.6 South Africa Alpha Glucosidase Inhibitors Sales and Growth Rate (2014-2019)
10 Global Alpha Glucosidase Inhibitors Market Segment by Type
    10.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Alpha Glucosidase Inhibitors Sales and Market Share by Type (2014-2019)
        10.1.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Type (2014-2019)
    10.2 Dumping Syndrome Sales Growth and Price
        10.2.1 Global Dumping Syndrome Sales Growth (2014-2019)
        10.2.2 Global Dumping Syndrome Price (2014-2019)
    10.3 Type 2 Diabetes Sales Growth and Price
        10.3.1 Global Type 2 Diabetes Sales Growth (2014-2019)
        10.3.2 Global Type 2 Diabetes Price (2014-2019)
11 Global Alpha Glucosidase Inhibitors Market Segment by Application
    11.1 Global Alpha Glucosidase Inhibitors Sales Market Share by Application (2014-2019)
    11.2 Online Pharmacies Sales Growth (2014-2019)
    11.3 Retail Pharmacies Sales Growth (2014-2019)
    11.4 Hospital Pharmacies Sales Growth (2014-2019)
12 Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
    12.1 Global Alpha Glucosidase Inhibitors Sales, Revenue and Growth Rate (2019-2024)
    12.2 Alpha Glucosidase Inhibitors Market Forecast by Regions (2019-2024)
        12.2.1 North America Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
        12.2.2 Europe Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
        12.2.4 South America Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Alpha Glucosidase Inhibitors Market Forecast (2019-2024)
    12.3 Alpha Glucosidase Inhibitors Market Forecast by Type (2019-2024)
        12.3.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Type (2019-2024)
        12.3.2 Global Alpha Glucosidase Inhibitors Market Share Forecast by Type (2019-2024)
    12.4 Alpha Glucosidase Inhibitors Market Forecast by Application (2019-2024)
        12.4.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Application (2019-2024)
        12.4.2 Global Alpha Glucosidase Inhibitors Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Reports
Global Population Health Management Market Research Report 2017

The Global Population Health Management Market Research Report provides a detailed market overview along with the analysis of industry’s gross  read more..


Global Water Distiller Market Insights, Forecast to 2025

Water Distiller Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Report 2017

The EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Research Report provides a detailed market overview along with the analysis of  read more..


Global Health Insurance Market Report 2019-2025

The Health Insurance market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report also  read more..


Global Boat First Aid Kits Industry 2016 Market Research Report

The Global Boat First Aid Kits Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Boat First Aid Kits  read more..


Global Facial Aesthetics Market Report 2018-2025

The Global Facial Aesthetics Market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This  read more..


Global Spinal Fixation Systems Market Research Report 2017

The Global Spinal Fixation Systems Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin,  read more..


Global Vascular Graft Market Insights, Forecast to 2025

Vascular Graft Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Blood Products Market Insights, Forecast to 2025

Blood Products Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Nateglinide Market Research Report 2021

The Global Nateglinide Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..